Cite
MLA Citation
P. Ghia et al.. “AN ONGOING PHASE 2 STUDY OF IBRUTINIB COMBINED WITH VENETOCLAX IN PATIENTS WITH TREATMENT‐NAÏVE CLL/SLL.” Hematological oncology, vol. 35, n.d., p. 428. http://access.bl.uk/ark:/81055/vdc_100047420017.0x00002f